Table 1.
Syndrome | Principal clinical features | Mitochondrial DNA mutation |
---|---|---|
CPEO | External ophthalmoplegia, myopathy | Single or multiple mtDNA deletions |
Kearns-Sayre syndrome | Pigmentary retinopathy, ataxia, cardiac conduction defects | Single, large-scale mtDNA deletion |
Leigh syndrome | Subacute necrotizing encephalopathy, basal ganglia lesions | Complex I, IV, and V gene mutations |
LHON | Acute or sub-acute visual loss | Complex I gene mutations |
MELAS | Myopathy, encephalopathy, lactic acidosis, stroke-like episodes | mt-tRNA gene mutations |
MERRF | Myoclonus, epilepsy, ataxia | mt-tRNA gene mutations |
NARP | Neuropathy, ataxia, pigmentary retinopathy | Complex V mutations |
Pearson's marrow-pancreas syndrome | Sideroblastic anaemia, exocrine pancreatic insufficiency, hepatopathy, nephropathy | Single, large-scale mtDNA deletion |
CPEO, chronic progressive external ophthalmoplegia; LHON, Leber's hereditary optic neuropathy; MELAS, myopathy, encephalopathy, and lactic acidosis with stroke-like episodes; MERRF, mitochondrial encephaolopathy with ragged red fibres; mtDNA, mitochondrial DNA; NARP, neurogenic ataxia and retinitis pigmentosa.